| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | 104fea5c-cb2a-16c3-e054-00144ff88e88 | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN | 6 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 5 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | c6d56d5e-856e-4e48-85f7-fce2beade4d1 | 4 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 6 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR AUROBINDO | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP | 2 | |
| Cephalexin Anhydrous | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | eac25cfc-92cb-411c-b109-25731815b936 | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR ORAL SUSPENSION USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE INGREDIENT | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR ORAL SUSPENSION, USP Rx only | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP | 5 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and other antibacterial drugs, cephalexin capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN - 500 MG - CAPSULES | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR ORAL SUSPENSION USP | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsule | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | b5da860d-9cfc-4020-bc81-11f2a01e660b | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 4 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 4 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | d9a049bd-2161-4a9b-8f6d-0c7d2bfdb0ed | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | Cephalexin for Oral Suspension USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE INGREDIENT | 5SFF1W6677 | Cephalexin for Oral Suspension USP | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN (CEPHALEXIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 22 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 21 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 18 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] | 13 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] | 11 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | KEFLEX (CEPHALEXIN) CAPSULE [SHIONOGI INC.] | 10 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [ORCHIDPHARMA INC] | 9 | |
| Cephalexin Anhydrous | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [CARLSBAD TECHNOLOGY, INC.] | 8 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN (CEPHALEXIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 7 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED] | 6 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 6 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 5 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN SUSPENSION [WEST-WARD PHARMACEUTICAL CORP] | 5 | |
| Cephalexin Anhydrous | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [AVKARE, INC.] | 4 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 4 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [NORTHWIND PHARMACEUTICALS] | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [AVPAK] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [DIRECT RX] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [GEN-SOURCE RX] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [VIRTUS PHARMACEUTICALS, LLC] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [PROFICIENT RX LP] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 2 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | FISH FLEX (CEPHALEXIN) CAPSULE [THOMAS LABS, LLC] | 2 | |
| cephalexin anhydrous | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN (CEPHALEXIN) CAPSULE CEPHALEXIN (CEPHALEXIN) SUSPENSION [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [AMERICAN HEALTH PACKAGING] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [NORTHWIND PHARMACEUTICALS, LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [NORTHWIND PHARMACEUTICALS] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [REMEDYREPACK INC. ] | 1 | |
| cephalexin anhydrous | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [VIRTUS PHARMACEUTICALS] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN POWDER, FOR SUSPENSION [REMEDYREPACK INC. ] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN SUSPENSION [DIRECT RX] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | FISH FLEX FORTE (CEPHALEXIN) CAPSULE [THOMAS LABS, LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | RILEXINE (CEPHALEXIN) TABLET, CHEWABLE [VIRBAC AH, INC] | 1 | |